Plain-English translation of NCT06889662 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The GEAM study is investigating whether genetic testing can help doctors better understand and predict dangerous heart rhythms in young patients with myocarditis—inflammation of the heart muscle. Researchers will compare genetic material from patients who experience abnormal heartbeats with those who don't, to see if certain genetic patterns make some people more vulnerable to life-threatening arrhythmias. This information could eventually help doctors identify at-risk patients earlier and prevent sudden cardiac death in young people.
Heart inflammation with dangerous rhythms is a leading cause of sudden cardiac death in young people, but doctors don't yet have reliable ways to predict who will develop these life-threatening arrhythmias. Recent research suggests that genetic factors may play a role, but this hasn't been thoroughly studied in patients with heart inflammation—so this trial aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be placed into one of two groups based on whether you have experienced ventricular arrhythmias (dangerous heart rhythms). You'll have your heart monitored with an electrocardiogram and will be asked to donate blood and possibly heart tissue samples for genetic analysis. The researchers will compare your genetic information with that of healthy volunteers to identify patterns that might predict who develops dangerous rhythms.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Italy